Your browser doesn't support javascript.
loading
Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma.
Bowden, John A; Heckert, Alan; Ulmer, Candice Z; Jones, Christina M; Koelmel, Jeremy P; Abdullah, Laila; Ahonen, Linda; Alnouti, Yazen; Armando, Aaron M; Asara, John M; Bamba, Takeshi; Barr, John R; Bergquist, Jonas; Borchers, Christoph H; Brandsma, Joost; Breitkopf, Susanne B; Cajka, Tomas; Cazenave-Gassiot, Amaury; Checa, Antonio; Cinel, Michelle A; Colas, Romain A; Cremers, Serge; Dennis, Edward A; Evans, James E; Fauland, Alexander; Fiehn, Oliver; Gardner, Michael S; Garrett, Timothy J; Gotlinger, Katherine H; Han, Jun; Huang, Yingying; Neo, Aveline Huipeng; Hyötyläinen, Tuulia; Izumi, Yoshihiro; Jiang, Hongfeng; Jiang, Houli; Jiang, Jiang; Kachman, Maureen; Kiyonami, Reiko; Klavins, Kristaps; Klose, Christian; Köfeler, Harald C; Kolmert, Johan; Koal, Therese; Koster, Grielof; Kuklenyik, Zsuzsanna; Kurland, Irwin J; Leadley, Michael; Lin, Karen; Maddipati, Krishna Rao.
Afiliação
  • Bowden JA; Marine Biochemical Sciences Group, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC john.bowden@nist.gov.
  • Heckert A; Statistical Engineering Division, National Institute of Standards and Technology, Gaithersburg, MD.
  • Ulmer CZ; Marine Biochemical Sciences Group, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC.
  • Jones CM; Marine Biochemical Sciences Group, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC.
  • Koelmel JP; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
  • Abdullah L; The Roskamp Institute, Sarasota, FL.
  • Ahonen L; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Alnouti Y; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE.
  • Armando AM; Departments of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA.
  • Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA.
  • Bamba T; Department of Medicine, Harvard Medical School, Boston, MA.
  • Barr JR; Division of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, Japan.
  • Bergquist J; Division of Laboratory Sciences, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA.
  • Borchers CH; Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Uppsala, Sweden.
  • Brandsma J; University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada.
  • Breitkopf SB; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
  • Cajka T; Gerald Bronfman Department of Oncology McGill University, Montreal, Quebec, Canada.
  • Cazenave-Gassiot A; Proteomics Centre, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Checa A; Faculty of Medicine, Academic Unit of Clinical and Experimental Sciences, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.
  • Cinel MA; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA.
  • Colas RA; National Institutes of Health West Coast Metabolomics Center, University of California Davis Genome Center, Davis, CA.
  • Cremers S; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore and Singapore Lipidomic Incubator (SLING), Life Sciences Institute, Singapore.
  • Dennis EA; Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Evans JE; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Fauland A; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Fiehn O; Biomarker Core Laboratory, Irving Institute for Clinical and Translational Research, Columbia University Medical Center, New York, NY.
  • Gardner MS; Departments of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA.
  • Garrett TJ; The Roskamp Institute, Sarasota, FL.
  • Gotlinger KH; Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Han J; National Institutes of Health West Coast Metabolomics Center, University of California Davis Genome Center, Davis, CA.
  • Huang Y; Biochemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Neo AH; Division of Laboratory Sciences, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA.
  • Hyötyläinen T; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
  • Izumi Y; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, NY.
  • Jiang H; University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada.
  • Jiang H; Thermo Fisher Scientific, San Jose, CA.
  • Jiang J; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore and Singapore Lipidomic Incubator (SLING), Life Sciences Institute, Singapore.
  • Kachman M; Department of Chemistry, Örebro University, Örebro, Sweden.
  • Kiyonami R; Division of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, Japan.
  • Klavins K; Biomarker Core Laboratory, Irving Institute for Clinical and Translational Research, Columbia University Medical Center, New York, NY.
  • Klose C; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, NY.
  • Köfeler HC; Departments of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA.
  • Kolmert J; Metabolomics Core, BRCF, University of Michigan, Ann Arbor, MI.
  • Koal T; Thermo Fisher Scientific, San Jose, CA.
  • Koster G; Biocrates Life Sciences AG, Innsbruck, Austria.
  • Kuklenyik Z; Lipotype GmbH, Dresden, Germany.
  • Kurland IJ; Core Facility for Mass Spectrometry, Medical University of Graz, Graz, Austria.
  • Leadley M; Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Lin K; Biocrates Life Sciences AG, Innsbruck, Austria.
  • Maddipati KR; Faculty of Medicine, Academic Unit of Clinical and Experimental Sciences, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.
J Lipid Res ; 58(12): 2275-2288, 2017 12.
Article em En | MEDLINE | ID: mdl-28986437
ABSTRACT
As the lipidomics field continues to advance, self-evaluation within the community is critical. Here, we performed an interlaboratory comparison exercise for lipidomics using Standard Reference Material (SRM) 1950-Metabolites in Frozen Human Plasma, a commercially available reference material. The interlaboratory study comprised 31 diverse laboratories, with each laboratory using a different lipidomics workflow. A total of 1,527 unique lipids were measured across all laboratories and consensus location estimates and associated uncertainties were determined for 339 of these lipids measured at the sum composition level by five or more participating laboratories. These evaluated lipids detected in SRM 1950 serve as community-wide benchmarks for intra- and interlaboratory quality control and method validation. These analyses were performed using nonstandardized laboratory-independent workflows. The consensus locations were also compared with a previous examination of SRM 1950 by the LIPID MAPS consortium. While the central theme of the interlaboratory study was to provide values to help harmonize lipids, lipid mediators, and precursor measurements across the community, it was also initiated to stimulate a discussion regarding areas in need of improvement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benchmarking / Ensaio de Proficiência Laboratorial / Lipídeos Limite: Humans Idioma: En Revista: J Lipid Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Ilhas Seychelles

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benchmarking / Ensaio de Proficiência Laboratorial / Lipídeos Limite: Humans Idioma: En Revista: J Lipid Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Ilhas Seychelles